Detalhe da pesquisa
1.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med
; 385(20): 1856-1867, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534429
2.
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(4): 392-402, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878237
3.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053112
4.
Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).
J Cancer Educ
; 34(1): 14-18, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779441
5.
Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer.
Cancer
; 121(3): 413-22, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278038
6.
A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: a study of the Princess Margaret, Chicago and California Consortia.
Gynecol Oncol
; 134(2): 274-80, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882554
7.
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Clin Genitourin Cancer
; : 102060, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521648
8.
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
JAMA Oncol
; 10(2): 185-192, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095881
9.
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Eur Urol Oncol
; 7(3): 570-580, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097481
10.
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
J Clin Oncol
; 41(36): 5505-5511, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910822
11.
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System.
JCO Glob Oncol
; 9: e2300271, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992270
12.
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Can Urol Assoc J
; 17(5): E154-E163, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185210
13.
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.
Cancer Lett
; 553: 215994, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343786
14.
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients.
Clin Genitourin Cancer
; 20(3): 210-218, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115252
15.
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
Adv Radiat Oncol
; 7(4): 100899, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35814860
16.
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328377
17.
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer.
Eur J Cancer
; 49(1): 121-31, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22921155
18.
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study.
Clin Cancer Res
; 19(19): 5485-93, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23922302
19.
Acute oxalate nephropathy induced by oral high-dose vitamin C alternative treatment.
Clin Kidney J
; 7(2): 218, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24944785
20.
Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage.
Proc Natl Acad Sci U S A
; 99(1): 245-50, 2002 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-11756665